Dr Michael Carter

Title: PiRAMiD: Predicting early onset Autism through Maternal Immune Activation and Proteomic Discovery

Michael is investigating the potential contributory role of maternal immune activation (MIA) in Autism Spectrum Disorder risk in offspring. In a matched ASD cohort, and through a combination of cytokine analysis, proteomics, and metabolomics, Michael aims to identify specific inflammatory, protein or metabolite signatures during pregnancy which may act as a biomarker for early ASD detection in offspring. Clinically, he is examining the clinical features of the cohort including the evolution of emotional and behavioural problems (EBP) over time, and advocates for early EBPs screening in ASD cohorts.